// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Clinical presentation and management and outcomes of disconnected pancreatic duct syndrome: a systematic review and meta-analysis

E.J.F. Chong - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Resected pancreatic ductal adenocarcinoma: understanding tumour tropism to maximise benefit from surgery

M. Frizziero - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

In silico investigation and functional enrichment analysis of the human major intrinsic proteins and voltage-gated chloride channel proteins reveal eleven prognostic biomarkers for pancreatic cancer

D. Magouliotis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Sporadic vs. MEN-associated pancreatic neuroendocrine tumors: multi-institutional clinicopathologic comparison

J. Bergquist - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic Neuroendocrine Tumors

N/A

Factors associated with access to treatment for pancreatic cancer in New Zealand

J. Oo - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Metaanalysis of recurrence and survival after resection for pancreatic neuroendocrine tumours (PNETs)

K. Asanai - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreatic Neuroendocrine Tumors

N/A

Transition from open and laparoscopic to robotic pancreaticoduodenectomy in a UK tertiary referral hepatobiliary and pancreatic centre - early experience of robotic Pancreaticoduodenectomy

T. Gall - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Validation of the SORT score in greek patients with pancreatic cancer undergoing surgery and comparison with POSSUM and P-POSSUM

D. Magouliotis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreato-biliary malignancies

N/A

Prehabilitation before oncological pancreatic resection: a systematic review of available evidence

J. Bundred - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Predicting post-operative pancreatic fistula: a systematic review of scoring systems

L. Phelan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interventions to reduce post-operative pancreatic fistula after pancreaticoduodenectomy - do we need a change of direction? a systematic review and meta-analysis

J. Halle-Smith - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pancreaticoduodenectomy performed by surgeons in training and the risk of post-operative fistula: a systematic review and meta-analysis

D. Broadhurst - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The efficacy of radiofrequency ablation (RFA) in locally advanced pancreatic ductal adenocarcinoma

O. Hadjicosta - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Pancreas ductal adenocarcinoma

N/A

Exploring the psychological impact of living with and after cancer following major pancreatic surgery: a qualitative study

A. Taylor - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Study of a rare benign gangliocytic paraganglioma within the ampulla of vater

M. Ilyas - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Paraganglioma

N/A

Neoadjuvant Chemoradiotherapy before Resection of Peri-Hilar Cholangiocarcinoma (PH-CCA): The Current World Experience

M. Baltatzis - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Klatskin tumors

N/A

Staging Laparoscopy Is Unnecessary in the Pre-Surgical Work-Up of Patients with Peri-Hilar Cholangiocarcinoma (PH-CCA)

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

Contemporary Surgical Management of Peri-Hilar Cholangiocarcinoma (PH-CCA)

H.V. Spiers - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Advanced biliary tract carcinoma

N/A

Subtotal Cholecystectomy: Is it Really a Safe Option?

R. Ibrahim - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Snapshot of the Practice of Laparoscopic Common Bile Duct Exploration in the United Kingdom - (CholeS Data Set)

A. Tanase - International Hepato-Pancreato-Biliary Association (IHPBA) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved